How to manage intolerance to dopamine agonist in patients with prolactinoma
Matheo Augusto Morandi Stumpf, Felipe Moura Maia Pinheiro, Gilberto Ochman da Silva, Valter Ângelo Sperling Cescato, Nina Rosa de Castro Musolino, Malebranche Berardo Carneiro Cunha-Neto, Andréa Glezer
Topics & Concepts
CabergolineMedicineTolerabilityProlactinomaDopamine agonistIntensive care medicineDopamineInternal medicineAdverse effectHormoneDopaminergicProlactinPituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsAdrenal Hormones and Disorders